{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:37:00Z","timestamp":1791599820739,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00393-023-01462-y","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T10:02:38Z","timestamp":1702893758000},"page":"242-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of orexin in fatigue and sleep quality in patients with primary Sj\u00f6gren\u2019s syndrome","Die Rolle von Orexin bei Fatigue und Schlafqualit\u00e4t bei Patienten mit prim\u00e4rem Sj\u00f6gren-Syndrom"],"prefix":"10.1007","volume":"83","author":[{"given":"Sevinc Can","family":"Sandikci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcan","family":"Gultuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Ozisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fevzi Nuri","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1590\/1807-3107bor-2017.vol31.0008","volume":"31","author":"LM Ambrosio","year":"2017","unstructured":"Ambrosio\u00a0LM, Rovai\u00a0ES, Franca\u00a0BN et\u00a0al (2017) Effects of periodontal treatment on primary sjogren\u2019s syndrome symptoms. Braz oral res 31:e8","journal-title":"Braz oral res"},{"key":"1462_CR2","doi-asserted-by":"publisher","first-page":"E579","DOI":"10.1503\/cmaj.122037","volume":"186","author":"CP Mavragani","year":"2014","unstructured":"Mavragani\u00a0CP, Moutsopoulos\u00a0HM (2014) Sj\u00f6gren syndrome. Cmaj 186:E579\u2013E586","journal-title":"Cmaj"},{"key":"1462_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/rheumatology\/keq023","volume":"49","author":"L Theander","year":"2010","unstructured":"Theander\u00a0L, Strombeck\u00a0B, Mandl\u00a0T, Theander\u00a0E (2010) Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary sjogren\u2019s syndrome? Rheumatol (Oxford) 49:1177\u20131183","journal-title":"Rheumatol (Oxford)"},{"key":"1462_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3389\/fendo.2019.00709","volume":"10","author":"C Alain","year":"2019","unstructured":"Alain\u00a0C, Thierry\u00a0V, Pascal\u00a0N, Val\u00e9rie\u00a0G, Catalina\u00a0A, Yossan-VT (2019) Orexins as novel therapeutic targets in inflammatory and neurodegenerative diseases. Front Endocrinol (Lausanne) 10:709","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1462_CR5","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror\u00a0R, Ravaud\u00a0P, Mariette\u00a0X et\u00a0al (2011) EULAR Sj\u00f6gren\u2019s syndrome patient reported index (ESSPRI): development of a\u00a0consensus patient index for primary sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 70:968\u2013972","journal-title":"Ann Rheum Dis"},{"key":"1462_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror\u00a0R, Theander\u00a0E, Brun\u00a0JG et\u00a0al (2015) Validation of EULAR primary sjogren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74:859\u2013866","journal-title":"Ann Rheum Dis"},{"key":"1462_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.sleep.2010.04.020","volume":"12","author":"AN Bertolazi","year":"2011","unstructured":"Bertolazi\u00a0AN, Fagondes\u00a0SC, Hoff\u00a0LS, Dartora\u00a0EG, Miozzo\u00a0IC, de Barba\u00a0ME, Barreto\u00a0SS (2011) Validation of the Brazilian Portuguese version of the Pittsburgh sleep quality index. Sleep Med 12:70\u201375","journal-title":"Sleep Med"},{"key":"1462_CR8","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.2147\/IJGM.S360544","volume":"15","author":"S Dong-Sheng","year":"2022","unstructured":"Dong-Sheng\u00a0S, Shao-Kun\u00a0X, Lin\u00a0W, Li\u00a0Z, Hai-Yan\u00a0Y, Juan-Qin\u00a0S (2022) The weighted combination of the epworth sleepiness scale and the STOP-bang questionnaire improved the predictive value of for OSAHS in hypertensive patients. Int J Gen Med 15:6909\u20136915","journal-title":"Int J Gen Med"},{"key":"1462_CR9","first-page":"584","volume":"16","author":"CW Karolina","year":"2019","unstructured":"Karolina\u00a0CW, Pawe\u0142\u00a0R, Ma\u0142gorzata\u00a0W, Ilona\u00a0P, Maciej\u00a0W (2019) Health-related quality of life (Nottingham health profile) in patients with endometriomas: correlation with clinical variables and self-reported limitations. Arch Med Sci 16:584\u2013591","journal-title":"Arch Med Sci"},{"key":"1462_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp\u00a0LB, Larocca\u00a0NG, Muir-Nash\u00a0J, Steinberg\u00a0AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123","journal-title":"Arch Neurol"},{"key":"1462_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/rheumatology\/35.3.275","volume":"35","author":"AJ Carr","year":"1996","unstructured":"Carr\u00a0AJ, Thompson\u00a0PW, Kirwan\u00a0JR (1996) Quality of life measures. Br J Rheumatol 35:275\u2013281","journal-title":"Br J Rheumatol"},{"key":"1462_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1","volume":"62","author":"JG Sutcliffe","year":"2000","unstructured":"Sutcliffe\u00a0JG, de Lecea\u00a0L (2000) The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J\u00a0Neurosci Res 62:161\u2013168","journal-title":"J Neurosci Res"},{"key":"1462_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-642-24716-3_4","volume":"209","author":"JP Nixon","year":"2012","unstructured":"Nixon\u00a0JP, Kotz\u00a0CM, Novak\u00a0CM, Billington\u00a0CJ, Teske\u00a0JA (2012) Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 209:77\u2013109","journal-title":"Handb Exp Pharmacol"},{"key":"1462_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.smrv.2007.09.001","volume":"12","author":"VC Abad","year":"2008","unstructured":"Abad\u00a0VC, Sarinas\u00a0PS, Guilleminault\u00a0C (2008) Sleep and rheumatologic disorders. Sleep Med Rev 12:211\u2013228","journal-title":"Sleep Med Rev"},{"key":"1462_CR15","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1186\/ar4054","volume":"14","author":"Y Li","year":"2012","unstructured":"Li\u00a0Y, Zhang\u00a0S, Zhu\u00a0J, Du\u00a0X, Huang\u00a0F (2012) Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a\u00a0casecontrol study. Arthritis Res Ther 14:R215","journal-title":"Arthritis Res Ther"},{"key":"1462_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3899\/jrheum.130430","volume":"41","author":"R Westhovens","year":"2014","unstructured":"Westhovens\u00a0R, Van der Elst\u00a0K, Matthys\u00a0A, Tran\u00a0M, Gilloteau\u00a0I (2014) Sleep problems in patients with rheumatoid arthritis. J\u00a0Rheumatol 41:31\u201340","journal-title":"J Rheumatol"},{"key":"1462_CR17","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/1756-185X.13104","volume":"21","author":"O Kucuksahin","year":"2018","unstructured":"Kucuksahin\u00a0O, Omma\u00a0A, Ozdemirel\u00a0AE et\u00a0al (2018) Incidence of sleep disturbances in patients with familial Mediterranean fever and the relation of sleep quality with disease activity. Int J Rheum Dis 21:1849\u20131856","journal-title":"Int J Rheum Dis"},{"key":"1462_CR18","first-page":"71","volume":"15","author":"M Tishler","year":"1997","unstructured":"Tishler\u00a0M, Barak\u00a0Y, Paran\u00a0D, Yaron\u00a0M (1997) Sleep disturbances, fibromyalgia and primary sjogren\u2019s syndrome. Clin Exp Rheumatol 15:71\u201374","journal-title":"Clin Exp Rheumatol"},{"key":"1462_CR19","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/rheumatology\/32.12.1072","volume":"32","author":"B Gudbjornsson","year":"1993","unstructured":"Gudbjornsson\u00a0B, Broman\u00a0JE, Hetta\u00a0J, Hallgren\u00a0R (1993) Sleep disturbances in patients with primary sjogren\u2019s syndrome. Br J Rheumatol 32:1072\u20131076","journal-title":"Br J Rheumatol"},{"key":"1462_CR20","first-page":"373","volume":"34","author":"R Priori","year":"2016","unstructured":"Priori\u00a0R, Minniti\u00a0A, Antonazzo\u00a0B, Fusconi\u00a0M, Valesini\u00a0G, Curcio\u00a0G (2016) Sleep quality in patients with primary sjogren\u2019s syndrome. Clin Exp Rheumatol 34:373\u2013379","journal-title":"Clin Exp Rheumatol"},{"key":"1462_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron\u00a0C, Faraco\u00a0J, Rogers\u00a0W et\u00a0al (2000) A mutation in a\u00a0case of early onset narcolepsy and a\u00a0generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991\u2013997","journal-title":"Nat Med"},{"key":"1462_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal\u00a0TC, Moore\u00a0RY, Nienhuis\u00a0R et\u00a0al (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469\u2013474","journal-title":"Neuron"},{"key":"1462_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2869.2011.00943.x","volume":"21","author":"HA Droogleever Fortuyn","year":"2012","unstructured":"Droogleever Fortuyn\u00a0HA, Fronczek\u00a0R, Smitshoek\u00a0M et\u00a0al (2012) Severe fatigue in narcolepsy with cataplexy. J\u00a0Sleep Res 21:163\u2013169","journal-title":"J Sleep Res"},{"key":"1462_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbi.2013.11.003","volume":"37","author":"KB Weymann","year":"2014","unstructured":"Weymann\u00a0KB, Wood\u00a0LJ, Zhu\u00a0X, Marks\u00a0DL (2014) A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun 37:84\u201394","journal-title":"Brain Behav Immun"},{"key":"1462_CR25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/0269881111408954","volume":"26","author":"P Bettica","year":"2012","unstructured":"Bettica\u00a0P, Nucci\u00a0G, Pyke\u00a0C et al (2012) Phase\u00a0I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a\u00a0novel dual orexin receptor antagonist. J\u00a0Psychopharmacol 26:1058\u20131070","journal-title":"J Psychopharmacol"},{"key":"1462_CR26","doi-asserted-by":"publisher","first-page":"e1918254","DOI":"10.1001\/jamanetworkopen.2019.18254","volume":"2","author":"R Rosenberg","year":"2019","unstructured":"Rosenberg\u00a0R, Murphy\u00a0P, Zammit\u00a0G et\u00a0al (2019) Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a\u00a0phase\u00a03 randomized clinical trial. JAMA Netw Open 2:e1918254","journal-title":"JAMA Netw Open"},{"key":"1462_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/OARRR.S167990","volume":"11","author":"ST Miyamoto","year":"2019","unstructured":"Miyamoto\u00a0ST, Lendrem\u00a0DW, Ng\u00a0W\u2011F, Hackett\u00a0KL, Valim\u00a0V (2019) Managing fatigue in patients with primary sj\u00f6gren\u2019s syndrome: challenges and solutions. Open Access Rheumatol 11:77\u201388","journal-title":"Open Access Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01462-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T08:06:20Z","timestamp":1708416380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01462-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":27,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01462-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"27 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.C.\u00a0Sandikci, S.\u00a0Gultuna, C.\u00a0Ozisler and F.\u00a0N.\u00a0Aydin declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}